Revolution will now explore daraxonrasib’s potential as a monotherapy and in combination with chemotherapy in late-stage PDAC ...

In August, Regeneron announced positive results from Phase III clinical trial NIMBLE evaluating the efficacy and safety of ...

PhaseV has entered into a strategic partnership with Bioforum to enhance the efficiency of clinical trials using advanced ...

These readouts will help Regeneron structure the confirmatory trials for the two allergy combination therapies.

AstraZeneca's Tagrisso, in combination with pemetrexed and platinum-based chemotherapy, has shown a significant improvement ...

Transformative new shifts have taken place in the last month in the metabolic dysfunction-associated steatohepatitis (MASH) ...

As the IASLC 2025 World Conference on Lung Cancer approaches, CTA looks at some of the most promising NSCLC assets in Phase ...

Takeda’s readout comes from two pivotal Phase III trials of its OX2R, with Alkermes’ data coming from a Phase II trial in NT1 ...

Sanofi’s stock dropped in the wake of data from its Phase III trial of atopic dermatitis (AD) candidate amlitelimab, which ...

In the real-world trial, Novo Nordisk's Wegovy showed a significant reduction in CV events compared to Eli Lilly’s Zepbound.

RealTime eClinical Solutions has rolled out the TrialAlign platform that aims to refine the performance analytics for ...

In this podcast, Steve Bulera discusses the current state of the animal-alternative testing space, as well as the sector's ...